Onderneming Tianjin Chase Sun Pharmaceutical Co.,Ltd
Aandelen
300026
CNE100000GF1
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,9 CNY | +0,52% | -3,47% | -8,02% |
Vakgebied
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Traditional Chinese Medicine Formula Granules and Decoction Pieces
47,9
%
| 3 360 | 50,5 % | 2 923 | 47,9 % | -12,99% |
Blood-essential Injection
13,9
%
| 817 | 12,3 % | 851 | 13,9 % | +4,23% |
Smart Pharmaceutical Supply Chain
11,7
%
| 588 | 8,8 % | 715 | 11,7 % | +21,66% |
Medical Device
6,3
%
| 674 | 10,1 % | 383 | 6,3 % | -43,12% |
Excipients
5,6
%
| 361 | 5,4 % | 344 | 5,6 % | -4,80% |
Low Molecular Weight Heparin Calcium Injection
4,7
%
| 305 | 4,6 % | 287 | 4,7 % | -5,82% |
Moxifloxacin Hydrochloride Sodium Chloride Injection
3,1
%
| 165 | 2,5 % | 189 | 3,1 % | +14,49% |
Other Products
3,1
%
| 233 | 3,5 % | 189 | 3,1 % | -18,85% |
API
2,6
%
| 147 | 2,2 % | 156 | 2,6 % | +6,07% |
Enoxaparin Sodium Injection
1,2
%
| - | - | 71 | 1,2 % | - |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
93,5
%
| 5 923 | 89,1 % | 5 167 | 93,5 % | -12,77% |
Overseas
6,5
%
| 727 | 10,9 % | 361 | 6,5 % | -50,29% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dan Zheng
CEO | Chief Executive Officer | 60 | - |
Wu Jun Lan
DFI | Director of Finance/CFO | 49 | - |
Wu Sun
BRD | Director/Board Member | 55 | - |
Dan Liang
BRD | Director/Board Member | 43 | 16-04-13 |
Rui Qiang Chen
HRO | Human Resources Officer | 47 | 25-06-15 |
Qin Pan
PRN | Corporate Officer/Principal | 54 | 26-04-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xiao Qing Yao
FOU | Founder | 59 | 23-09-96 |
Li Li
BRD | Director/Board Member | 63 | 18-11-20 |
Dan Zheng
CEO | Chief Executive Officer | 60 | - |
Wu Jun Lan
DFI | Director of Finance/CFO | 49 | - |
Da Wei Miao
BRD | Director/Board Member | 69 | 08-05-07 |
Dan Liang
BRD | Director/Board Member | 43 | 16-04-13 |
Tao Gong
BRD | Director/Board Member | 55 | 16-01-20 |
Sheng Tian Wang
BRD | Director/Board Member | 73 | 28-12-17 |
Xu Feng Pu
BRD | Director/Board Member | 61 | 16-01-20 |
Wu Sun
BRD | Director/Board Member | 55 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 004 154 837 | 826 252 275 ( 27,50 %) | 0 | 27,50 % |
Bedrijfsgegevens
Tianjin Chase Sun Pharmaceutical Co., Ltd.
B01 Building Entrepreneurship Headquarters Base
301700, Tianjin
+86 22 5962 3160
http://www.chasesun.cnSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,02% | 1,62 mld. | |
+23,32% | 5,42 mld. | |
-12,48% | 4,67 mld. | |
-6,70% | 3,27 mld. | |
-16,43% | 2,62 mld. | |
-2,41% | 2,54 mld. | |
-7,97% | 1,68 mld. | |
+24,37% | 1,66 mld. | |
-4,40% | 1,58 mld. | |
-8,51% | 1,42 mld. |
- Beurs
- Aandelen
- Aandeel Tianjin Chase Sun Pharmaceutical Co.,Ltd - Shenzhen S.E.
- Onderneming Tianjin Chase Sun Pharmaceutical Co.,Ltd